HLA-A*0301 & B2M

HLA-A*0301 & B2M Produktliste

Attribut
Protein (3)
Produktbibliothek
Online (3)
Spezies
Human (3)
Etikett
His Tag (2)His Tag & Avi Tag (1)
Marker
PE Labeled (1)Unconjugated (1)Biotin-labeled (1)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Vorbestellen/Bestellen
HLM-H52H3	Human	HEK293	Human HLA-A*03:01&B2M Monomer Protein (Peptide free, MALS verified)	In den Warenkorb legen
HLM-H82Ey	Human	HEK293	Biotinylated Human HLA-A*03:01&B2M Monomer Protein (Peptide free, MALS verified)	In den Warenkorb legen
HLM-HP2H6	Human	HEK293	PE-Labeled Human HLA-A*03:01&B2M Tetramer Protein (Peptide free)	In den Warenkorb legen

Gesamtmenge3

HLA-A*0301 & B2M Molekülhintergrund

Major histocompatibility complex (MHC), group of genes that code for proteins found on the surfaces of cells that help the immune system recognize foreign substances. MHC proteins are found in all higher vertebrates. In human beings the complex is also called the human leukocyte antigen (HLA) system.

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
Vopratelimab	JTX-2011	Phase 2 Clinical	Jounce Therapeutics Inc	Neoplasms; Carcinoma, Non-Small-Cell Lung	Details
Izuralimab	XmAb-23104; XmAb-104	Phase 2 Clinical	Xencor Inc	Sarcoma; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Endometrial Neoplasms; Colorectal Neoplasms; Breast Neoplasms; Nasopharyngeal Carcinoma; Solid tumours; Small Cell Lung Carcinoma; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Stomach Neoplasms; Esophageal Neoplasms	Details
Feladilimab	GSK-609; GSK-3359609	Phase 2 Clinical	Glaxosmithkline Plc	Head and Neck Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Multiple Myeloma	Details
Alomfilimab	KY-1044	Phase 2 Clinical	Kymab Ltd	Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Esophageal Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Pancreatic Neoplasms; Melanoma; Carcinoma, Hepatocellular; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis	Details
Acazicolcept	ALPN-101	Phase 2 Clinical		Graft vs Host Disease; Autoimmune Diseases; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Inflammation	Details
MEDI-570		Phase 1 Clinical	Japan Tobacco (Hong Kong) Ltd	Lymphoma, Follicular; Lupus Erythematosus, Systemic; Lymphoma, T-Cell, Cutaneous; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Mycosis Fungoides	Details
Anti-ICOS (Bristol Myers Squibb)	BMS-986226	Phase 1 Clinical	Bristol-Myers Squibb Company	Neoplasms	Details